Position in NTRA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$23,765,176
-$74,482,311 QoQ
Shares Held
87,549
-82.2% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#135
of 844 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AGF MANAGEMENT LTD holds $324,638,365 across 8 Diagnostics & Research names. NTRA ranks #3 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
1,364,815 | $239,975,420 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
68,779 | $34,483,038 | |
| 3 | NTRA |
Natera, Inc.
This page
|
87,549 | $23,765,176 | |
| 4 | RDNT |
RadNet, Inc.
|
188,565 | $11,628,803 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
29,009 | $5,605,118 | |
| 6 | DGX |
Quest Diagnostics Inc
|
15,592 | $3,304,724 | |
| 7 | LH |
Labcorp Holdings Inc.
|
11,694 | $3,274,320 | |
| 8 | DHR |
Danaher Corp /De/
|
13,659 | $2,601,766 |
All Filings in NTRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,765,176 | 87,549 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $98,247,487 | 491,262 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $108,618,441 | 474,130 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,179,266 | 7,326 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,301,976 | 13,626 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $17,464,276 | 123,501 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $18,377,205 | 116,091 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $12,511,430 | 98,554 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,672,412 | 98,554 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $5,660,002 | 61,885 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||